AMGN

Amgen

$292.95

-5.29 (-1.77%)

Analyst Overview

Target Price:
Date: 08.07.2025
$314.27
(+7.28%)
Strong Buy: 5
Buy: 10
Hold: 14
Sell: 2
Strong Sell: 1
Description:
Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. Focused on molecular biology and biochemistry, its goal is to provide a healthcare business based on recombinant DNA technology.
Exchange:
NASDAQ
Country:
USA
Sector:
LIFE SCIENCES
Industry:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Address:
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA, US
Fiscal year end:
December
Market capitalization:
$160 Billion
EBITDA:
$15.7 Billion
PERatio:
27.16
EPS:
10.98
Dividend per share:
$9.13
Dividend yield:
3.41%
Beta:
0.496

Dividends for 10 years

Income Statements for 10 years

Earnings calender

Income count if spend 1000$ ten years ago on shares

How much was you spent on shares:
$1,000
How much will you earn in 10 years:
+143%
How much will you get:
$2,434
Prices dates:
30-06-2015: $114.69 and 30-06-2025: $279.21